During her time away, the 23-time Grand Slam winner and former highest-earning woman in sport has expanded her business portfolio and inked major endorsement dealsincluding a multi-year partnership with Ro, a digital health platform that provides GLP-1 drugs for weight loss
Emerging Role of GLP-1 Agonists in Obesity: A Comprehensive Review of Randomised Controlled Trials (June 2023) Insufficient Sleep Predicts Poor Weight Loss Maintenance After 1 Year (May 2023) Stress and Obesity (January 2019) Once-Weekly Semaglutide in Adults With Overweight or Obesity (March 2021) The Effect of Semaglutide 2.4 mg Once Weekly on Energy Intake, Appetite, Control of Eating, and Gastric Emptying in Adults With Obesity (March 2021) Efficacy and Safety of Semaglutide for Weight Management: Evidence From the STEP Program (April 2022)
'[By July 1st], I had lost 15lbs and I felt better and that there was hope
Frias JP et al, The SYDNEY Device Study: A Multicenter, Randomized, Open-label Usability Study of a 2-mL Alirocumab Autoinjector Device
10.1073/pnas.1607152113 208 PacoldM